KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Sales: 2012-2025

Historic Return on Sales for Sarepta Therapeutics (SRPT) over the last 10 years, with Jun 2025 value amounting to -0.13%.

  • Sarepta Therapeutics' Return on Sales fell 17.00% to -0.13% in Q2 2025 from the same period last year, while for Jun 2025 it was -0.13%, marking a year-over-year decrease of 17.00%. This contributed to the annual value of 0.12% for FY2024, which is 55.00% up from last year.
  • Per Sarepta Therapeutics' latest filing, its Return on Sales stood at -0.13% for Q2 2025, which was down 208.88% from 0.12% recorded in Q4 2024.
  • In the past 5 years, Sarepta Therapeutics' Return on Sales registered a high of 0.12% during Q4 2024, and its lowest value of -1.23% during Q1 2021.
  • For the 3-year period, Sarepta Therapeutics' Return on Sales averaged around -0.33%, with its median value being -0.13% (2025).
  • As far as peak fluctuations go, Sarepta Therapeutics' Return on Sales slumped by 68bps in 2023, and later spiked by 116bps in 2024.
  • Sarepta Therapeutics' Return on Sales (Quarterly) stood at -0.60% in 2021, then decreased by 16bps to -0.75% in 2022, then skyrocketed by 32bps to -0.43% in 2023, then soared by 55bps to 0.12% in 2024, then fell by 17bps to -0.13% in 2025.
  • Its Return on Sales stands at -0.13% for Q2 2025, versus 0.12% for Q4 2024 and 0.07% for Q3 2024.